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Objective. Mass-media campaigns have been known to modify the outcome of low back pain (LBP). We assessed the impact
on outcome of standardized written information on LBP given to patients with acute LBP. Methods. Design: A 3-month
pragmatic, multicenter controlled trial with geographic stratification. Setting: Primary care practice in France. Participants:
2752 patients with acute LBP. Intervention: An advice book on LBP (the ‘‘back book’’). Main outcome measures: The main
outcome measure was persistence of LBP three months after baseline evaluation. Results. 2337 (85%) patients were assessed
at follow-up and 12.4% of participants reported persistent LBP. The absolute risk reduction of reporting persistent back pain in
the intervention group was 3.6% lower than in the control group (10.5% vs. 14.1%; 95% confidence interval [26.3% ; 21.0%]; p
value adjusted for cluster effect=0.01). Patients in the intervention group were more satisfied than those in the control group
with the information they received about physical activities, when to consult their physician, and how to prevent a new
episode of LBP. However, the number of patients who had taken sick leave was similar, as was the mean sick-leave duration, in
both arms, and, among patients with persistent pain at follow-up, the intervention and control groups did not differ in
disability or fear-avoidance beliefs. Conclusions. The level of improvement of an information booklet is modest, but the cost
and complexity of the intervention is minimal. Therefore, the implications and generalizability of this intervention are
substantial. Trial Registration. ClinicalTrials.gov NCT00343057
Citation: Coudeyre E, Tubach F, Rannou F, Baron G, Coriat F, et al (2007) Effect of a Simple Information Booklet on Pain Persistence after an Acute
Episode of Low Back Pain: A Non-Randomized Trial in a Primary Care Setting. PLoS ONE 2(8): e706. doi:10.1371/journal.pone.0000706
INTRODUCTION
About 60% of the population is concerned with low back pain
(LBP) in Western industrialized countries [1]. Chronic LBP (cLBP)
has become a major medical, social and economic problem [2].
The costs are comparable to those induced by coronary heart
disease, diabetes, or depression [3]. Diminishing the cost is a major
public health issue. An approach to achieving this goal is to
improve the prevention of chronic disease in patients with acute
LBP in primary care practice.
Psychosocial factors have been shown to be associated with the
development of disability with cLBP [4], and the best in-
dividualized factors are anxiety, depression, coping, and fear of
and belief about pain [5]. Providing advice to stay active and
information about how to cope with pain has been shown to
modify patients’ fears, avoidance attitudes and beliefs [6,7].
Because health care providers play a pivotal role in patient
information and education in primary care practice, general
practitioners (GPs) could greatly influence the outcome in LBP
and thus contribute to decreased LBP-related costs.
Several guidelines and reviews on the management of acute
LBP and cLBP in primary care practice are available [8–25]. They
mainly concern prescriptions for X-rays and laboratory tests,
treatment options, and information about physical and occupa-
tional activities. The consensus among international guidelines
seems to be that advice to stay active, reassurance and use of
analgesics, if necessary, for pain relief are important for acute
episodes of LBP. Specific exercises and occupational activities
seem to be useful for persistent but not acute LBP. Exercises,
education about back pain, behavioural treatment and multidis-
ciplinary treatment seem effective in preventing persistent/chronic
LBP. Concerning information given to patients, evidence suggests
that advice about staying active and coping with pain could
decrease the rate of patients experiencing chronic pain and the
impact of LBP on daily and occupational activities [23–25].
Information booklets, the lowest-cost information tools, have
been developed to help health care providers inform and educate
patients. Among these booklets [7,23–25], the ‘‘back book,’’
developed from evidence-based medicine by a multidisciplinary
team and published to accompany the United Kingdom back-pain
guidelines [26], has been shown, in a limited sample of English
patients with LBP, to significantly affect fears and beliefs about
and disability with LPB but not pain level [7]. Other educational
booklets or pamphlets have been previously assessed, with
relatively modest effects, for acute [27], chronic [28], or
occupational [29] back pain. The ‘‘back book’’ has been translated
with use of a validated translation/back translation procedure and
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PLoS ONE | www.plosone.org 1 August 2007 | Issue 8 | e706culturally adapted to French-speaking patients with LBP [30]. It is
the only evidence-based information booklet available for such
patients (i.e., ‘‘le Guide du dos’’) but has never been evaluated in
this setting.
The aim of this study was to assess the impact of the ‘‘back
book’’ on outcome (persistence of pain at 3 months) in acute LBP
in a French national sample of patients in a primary care setting.
METHODS
The protocol for this trial and supporting CONSORT checklist
are available as supporting information; see Checklist S1 and
Protocol S1.
Trial design
We conducted a 3-month prospective, controlled study with
a quasi-experimental design (i.e., a nonrandomized controlled
sample with geographic stratification [30 areas]). Control and
intervention areas were selected for their similarities in rural-to-
urban distribution of the population and patients’ access to GPs
and to minimize risk of overlap between areas.
Participants
GPs A total of 60 GPs per geographic area were selected at
random from a national database (Logimed) according to
a computerized allocation [31], and 1800 GPs were invited to
participate in the study. Those agreeing to participate were
assigned to the intervention or control group, depending on their
geographic area. Each GP in the intervention group received
a personal copy of the ‘‘back book’’ and was asked to read it before
including patients and explaining the booklet to patients. GPs in
the control group were told that they would get the book at the
end of the trial.
Patients Each GP had to enrol up to 4 consecutive patients
with acute LBP. Patients were excluded if they (a) were less than
18 years old; (b) had pain for more than 4 weeks; (c) had pain
intensity for the previous 24 hours less than 3 on a 11-point
numeric scale (0=no pain, 10=maximal pain); (d) had sciatica; (e)
had had a previous episode of acute LBP during the last
12 months; (f)did not work; (h) had consulted another
practitioner for the same episode of back pain; (i) were pregnant;
(j) had back pain related to infection, tumor, or inflammatory
disease; or (k) had previously undergone back surgery.
Ethical approval
The study protocol was approved by the Commission Nationale
Informatique et Liberte ´ and the French National Medical Council
(Conseil National de l’Ordre des Me ´decins). The study was
conducted in compliance with the protocol Good Clinical
Practices and Declaration of Helsinki principles. In accordance
with the French national law, GPs and patients gave their written
consent to participate after being informed about the study
protocol.
Intervention
At baseline, all patients received medical care and oral information
as usually provided by GPs. In the intervention group, all patients
also received the ‘‘back book.’’
Outcome measures
Main outcome measure To assess persistence of LBP
3 months after baseline evaluation, patients were asked to
answer Yes or No to the question ‘‘Has your low back pain
persisted since the first visit to your GP 3 months ago?’’ Patients
answering Yes were considered as having persistent back pain.
Physician questionnaire Parts 1, 2, and 3 of the physician
self-administered questionnaire completed at baseline concerned
demographic data (age and sex), professional data (years of
practice and exclusively private or public/private practice) and
personal history of LBP (acute, recurrent, chronic), and self-
limitation of physical activities for LBP (never, sometimes, often,
always), respectively. Part 4 dealt with GPs’ formation of practice
and practice for LBP: participation in an educational session on
LBP in the last 3 years (yes/no); mean length of sick leave
prescription for acute LBP if needed (#3 days, .3 and #8 days,
.8 days), advice about physical activities during sick leave for
acute LBP (bed rest, rest at home, keep maximum bearable
activities). Part 5 assessed GPs’ fears, avoidance attitudes and
beliefs on the Fear-Avoidance Beliefs Questionnaire (FABQ)[5],
which consists of 2 independent subscales: FABQ Phys and FABQ
Work. The FABQ Phys assesses fears, avoidance attitudes and
beliefs related to general physical activities (4 items, range 0–24),
and the FABQ Work assesses fears, avoidance attitudes and beliefs
related to occupational activities (7 items, range 0–42). Each item
is scored from 0, ‘‘do not agree at all,’’ to 6, ‘‘completely agree’’.
For both subscales, a low score indicates low fears, avoidance
attitudes and beliefs. According to the designers of the scale, a score
of 14 or more on the FABQ Phys scale indicates strong beliefs
[5,7]. This questionnaire has been validated in English [5],
German [32], and, recently, in French [33]. The FABQ was
originally developed to assess patients’ fears, avoidance attitudes
and beliefs. To evaluate GPs’ fears, avoidance attitudes and beliefs,
we did not modify the phrasing of items but slightly adapted the
first sentence of instructions to patients. This sentence was ‘‘these
are statements that other patients have expressed about their low
back pain…’’; we just deleted the word ‘‘other’’.
Patients’ questionnaire
Baseline evaluation
Baseline data were collected during the first visit to GPs. Patients
were interviewed about pain intensity (11-point numeric scale,
from 0, no pain, to 10, maximal pain), physical demand of
occupational activities (11-point numeric scale, from 0, no physical
demand, to 10, extremely hard physical demand), education level
(no full-time education, primary school, high school, post-graduate
education), presence of LBP in parents (yes/no), length of back
pain (days), work-related back pain (yes/no), sport activities (none,
occasional, regular, competition), medication intake for the
previous week (analgesics, nonsteroidal anti-inflammatory drugs
[NSAIDs], muscle relaxants), pain intensity for the last 48 hours
(weak, moderate, severe, extremely severe), and handicap level for
activities of daily living (no handicap, weak, moderate, severe,
extremely severe). Self-rated disability was assessed on the Quebec
questionnaire (20 items scored from 0, no disability, to 5,
impossible to do; range 0–100) [34]. LBP beliefs were recorded
on the FABQ (see GPs’ questionnaire).
3-month follow-up evaluation
At baseline, an appointment for a follow-up visit with the GP was
established for the patient. Follow-up data were recorded during
this visit to the GP (77% of patients) or by phone interviews (23%
of patients), conducted by trained research assistants for patients
who did not consult their physician. Patients were asked about
persistence of LBP since the baseline evaluation (yes/no); whether
radiography, computed tomography (CT), or magnetic resonance
imaging had been performed (yes/no); sick leave since baseline
evaluation (yes/no); sick leave duration (days); return to work (yes/
Clinical Trial
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activities, when to see a doctor, how to use medications, and how
to prevent new episodes of LBP (very satisfied, rather satisfied,
rather not satisfied, unsatisfied). For patients with persistent LBP,
pain intensity, level of handicap, perceived disability, anxiety and
depression, and LBP beliefs were recorded as during the baseline
evaluation.
Sample size
Persistent LBP after an acute episode has previously been reported
to occur in 7% of patients in France [35]. We hypothesized
(consensus among the authors) that a difference of 3 points
between control and intervention groups (7% in the control and
4% in the intervention groups) would have a clinical and public
health relevance. With a 2-sided chi-square test at 5%, a sample
size of 1212 patients per group would have 90% power for
detecting a significant difference between the control and
intervention groups. Allowing for 15% of patients lost to follow-
up at 3 months, we sought to recruit 2830 patients.
Statistical analysis
The impact of the ‘‘back book’’ intervention was assessed by
comparing the proportions of patients with persistent LBP after
3 months who had been exposed to the ‘‘back book’’ and those
who had not been exposed. Qualitative outcomes were compared
by chi-square test and quantitative outcomes by t-test. To take into
account the cluster effect (patients are clustered within physician),
the primary outcome (persistent pain) was also analysed in the
framework of a generalized estimation equation (GEE) regression
model, with the physician considered as a random effect. The
same procedure was applied to assess the impact of the ‘‘back
book’’ on the secondary outcomes.
The analysis was per protocol. We performed 2 intention-to-
treat analyses. In the first analysis, we considered all patients lost to
follow-up as having persistent pain at 3 months. In the second, we
considered all patients lost to follow-up as having no persistent
pain at 3 months.
Data analyses involved use of SAS (SAS institute Inc, Cary, NC).
RESULTS
Flow of participants through trial
The Logimed database contains information on 20 184 GPs. A
total of 60 GPs per geographic area were selected at random from
the database and asked to participate, with 1013 GPs agreeing to
participate. Of these, 88% returned their questionnaires, and 709
(70%) included at least 1 patient (Figure 1). Among the GPs who
agreed to participate, 488 were in intervention areas and 525 in
control areas, and 69.7% of GPs in the intervention and 70.3% in
the control areas returned their questionnaires and included at
least one patient.
A total of 2752 patients met the inclusion criteria, and 2337
(82.6%) (1135 and 1202 in the intervention and control groups,
respectively) were assessed at follow-up. At baseline, patients lost to
follow-up did not differ from those assessed at 3 months in terms of
age, gender, pain and handicap levels, sport activities, education
level, disability, and beliefs (table 1). The number of patients lost to
follow-up did not differ between the intervention and control
groups (209 [15.5%] and 206 [14.6%] respectively).
Baseline characteristics
Patients (Table 1) and GPs (Table 2) in the intervention and
control groups did not differ in baseline characteristics. The
patients’ mean (6SD) age was 45612 years, and 57% were male.
The median pain duration at baseline was 3 (median interquartile
range 5) days and pain level 6.861.5 (range 0–10). Before seeing
their GP, 81% of patients had taken analgesics, 26% NSAIDs, and
19% muscle relaxants. The Quebec disability scale mean score
was 55.0617.2 (range 0–100). Fears and beliefs were high, with
FABQ Phys and Work mean scores of 16.965.0 and 19.7610.9,
respectively. A total of 72% of patients had strong fears and beliefs
about back pain [5,7]. The GPs’ mean age was 4867 years; 79%
in both groups were male, 69% worked in an urban environment,
and 87% had more than 10 years of practice.
Impact of the intervention at 3-month follow-up
At 3-month follow-up, 12.4% of participants reported persistent
LBP. In the intervention group, the proportion of patients
experiencing persistent back pain was lower than in the control
group (10.5% vs. 14.1%; difference 23.6%; 95% CI [26.3% ;
21.0%]) (Table 3). The outcome was different depending on the
method used to collect data for the primary outcome. In the
intervention group, among patients reporting persistent pain, only
7.6% were assessed by phone interviews as compared with 25.6%
of those free of pain. A similar proportion was observed in the
control group, with 13.6% and 24.2% for those reporting pain and
those free of pain, respectively. In the intervention group,
persistent pain was reported by 3.5% of patients assessed by
phone and 12.7% by face-to-face interview. In the control group,
persistent pain was reported by 8.4% of those assessed by phone
and 15.7% by face-to-face interview. Finally, the method of
collecting data did not differ between groups (23.7% and 22.7% in
the intervention and control groups were assessed by phone
interview, respectively). For the current LBP episode, patients in
the intervention group were not less often referred to a spine
specialist and had a similar rate of spine imaging exams as patients
in the control group. The number of patients who had taken sick
leave was similar, as was the mean sick-leave duration in both
arms. Fewer patients had taken NSAIDs and muscle relaxants in
the intervention group than the control group. Patients in the
intervention group were more satisfied than those in the control
group about the information and advice they received about
physical activities, when to consult their physician, and how to
prevent a new episode of LBP but not more satisfied about advice
on medication intake. Adjusting for the cluster effect did not
change the crude results, except for referring to a spine specialist.
For intention-to-treat analysis on the main outcome measure,
we used sensitivity analysis on the primary outcome by considering
two extreme scenarios (worst and best-case imputation, respec-
tively). In the first scenario, we considered that all patients lost to
follow-up had persistent back pain at 3 months. The proportion of
patients reporting persistent back pain at 3 months was lower in
the intervention than in the control group, but the difference was
not significant (24.4% versus 26.7%; difference 22.3%; 95% CI
[21.0 ; 5.6]). However, for this scenario, the power of the test to
detect a statistically significant difference was only 25%. In the
second scenario, we considered that all patients lost to follow-up
had no persistent back pain at 3 months. The proportion of
patients reporting persistent back pain was lower in the
intervention than in the control group, but the difference was
significant (8.9% versus 12.1%; difference 23.2%; 95% CI [25.5 ;
21.0]). For this scenario, the power of the test was 70%.
Among patients with persistent pain at follow-up, the in-
tervention and control groups did not differ in disability (Quebec
mean score 31.0614.7 and 31.3615.5, respectively) or fear-
avoidance beliefs (FABQ Phys and Work mean scores 12.065.3
and 13.365.6, and 19.1610.3 and 19.8611.6, respectively).
Clinical Trial
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Interpretation
Our results suggest that providing the ‘‘back book’’ to patients
consulting their GPs for acute LBP can reduce the proportion of
patients reporting persistent pain at 3 months by 3.6% as
compared with patients who did not receive the book. Previous
studies have demonstrated a positive impact of such books for
patients [7] or physicians [36] in terms of beliefs about LBP,
patients’ satisfaction with information [23,24], patients’ knowledge
about LBP [25], and number of visits to GPs [37]. However, we
failed to demonstrate any effect of the book on disability and pain
level in patients reporting persistent pain and, as others, on work
absenteeism [29]. Our study is the first to report the impact of this
simple educational intervention on the outcome of patients with
acuteLBPinalargenationalsample.The‘‘backbook’’hasalsobeen
usedas apartofaninformation intervention including radioandTV
spots and newspaper advertising in a large mass-media campaign
about LBP in Australia, which had a short- [6] and long-term
positive impact [38] on claims and costs related to LBP. These
multimediainterventions are difficult to performand veryexpensive,
but booklets or pamphlets are simple to use and inexpensive.
The ‘‘back book’’ may have several other positive effects. We
observed a decrease of NSAID and myo-relaxant but not analgesic
intake in the intervention group. This observation is not surprising,
since advice about pain medications in this booklet recommends
grade I analgesics, especially paracetamol. The other positive
effect was patients’ satisfaction with information. Most of patients’
complaints and claims about medical procedures relate to lack of
information [39].
However,overallthe ‘‘backbook’’hadno effecton the othermain
back-pain outcomes: the number of sick leaves taken or sick-leave
duration and perceived disability in patients reporting persistent
pain. This observation had already been observed after occupational
low back injury [29]. More complex and expensive interventions
involving several participants may be required to reach this
objective. As compared with actual experience and behavioural
experiments,educationseemstobea weakintervention forchanging
attitudes and beliefs with cLBP [40]. Despite the existence of
guidelines [8], the mean sick-leave duration reported in this study
Figure 1. Flow of general practitioners and patients through the trial.
doi:10.1371/journal.pone.0000706.g001
Clinical Trial
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by the French sick-leave policy: GPs are free to order sick leave and,
until recently, sick leaves of less than one month received almost no
monitoring. Furthermore, during the first 3 months of sick leave,
most employees receive their entire salary.
The ‘‘back book’’ also had no effect on the rate of prescriptions
to undergo spine imaging. Almost 29% of patients underwent
plain radiography and 8% CT. Thus, GPs are not following
guidelines [8,9], which emphasizes the need for large-scale
education programs on this topic.
Finally, the effects of the ‘‘back book’’ may be underestimated in
this study, since GPs in the control group knew that the trial
assessed the impact of information on patients with LBP and may
have followed the guidelines more closely than under real-life
conditions.
Another important result is the high proportion of patients
reporting persistent pain after 3 months in the control group. This
proportion probably differs among countries [41], and the only
information available for France at the beginning of our study was
6.2% of patients consulting their GP for an acute episode of LBP
Table 1. Baseline demographic and clinical characteristics of patients
..................................................................................................................................................
Patients assessed at
follow-up N=2337 Intervention group N=1135 Control Group N=1202 Lost to follow-up N=412
Age (m6SD), years 45612 45612 44612 43612
Sex (M) 1321 (57%) 628 (56%) 693 (58%) 237 (57%)
Back pain duration (median (interquartile
range), days
3 (5) 3 (4) 4 (5) 3 (6)
Physical demand of work (0–10) (m6SD) 5.762.5 5.762.5 5.762.5 5.562.6
Education level
No full-time education 51 (2%) 27 (2%) 24 (2%) 7 (2%)
Primary school 656 (28%) 294 (26%) 362 (30%) 114 (28%)
High school 1075 (46%) 528 (47%) 547 (46%) 207 (50%)
Post graduate 552 (24%) 284 (25%) 268 (22%) 86 (20%)
Back pain in parents 1242 (54%) 593 (53%) 649 (55%) 198 (49%)
Work-related back pain 193 (8%) 95 (8%) 98 (8%) 37 (9%)
Sports activities
None 1061 (45%) 502 (45%) 559 (47%) 199 (48%)
Occasional 830 (36%) 411 (36%) 419 (35%) 133 (32%)
Usual 414 (18%) 207 (18%) 207 (17%) 76 (18%)
Competition 21 (1%) 10 (1%) 11 (1%) 4 (2%)
Medications*
Analgesics (yes) 1903 (81%) 929 (82%) 974 (81%) 322 (78%)
NSAIDs (yes) 611 (26%) 286 (25%) 325 (27%) 102 (25%)
Muscle-relaxants (yes) 434 (19%) 196 (17%) 238 (20%) 87 (21%)
Pain level (m6SD) 6.861.5 6.761.5 6.861.5 6.761.5
Pain intensity
None/weak 49 (2%) 24 (2%) 25 (2%) 11 (5%)
Moderate 485 (21%) 229 (20%) 256 (21%) 85 (21%)
Severe 1598 (69%) 777 (70%) 821 (69%) 276 (68%)
Extremely severe 181 (8%) 90 (8%) 91 (8%) 24 (6%)
Handicap level**
None/weak 78 (3%) 35 (3%) 43 (4%) 14 (3%)
Moderate 704 (30%) 328 (28%) 376 (31%) 131 (32%)
Severe 1352 (59%) 671 (60%) 681 (57%) 236 (59%)
Extremely severe 178 (8%) 85 (8%) 93 (8%) 23 (6%)
LBP beliefs
FABQ Phys (0–24) (m6SD) 16.965.0 16.765.0 17.164.9 16.265.0
FABQ Work (0–42) (m6SD) 19.7610.9 19.7611.1 19.7610.6 18.8610.8
Disability
Quebec (0–100) (m6SD) 55.0617.2 55.3616.9 54.7617.6 54.6617.6
Values are number of patients (percentages)
*for the last week
**for activities of daily living
NSAID=nonsteroidal anti-inflammatory drug; FABQ=Fear-Avoidance Beliefs Questionnaire
doi:10.1371/journal.pone.0000706.t001
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PLoS ONE | www.plosone.org 5 August 2007 | Issue 8 | e706having persistent LBP 7 weeks later [35]. The difference between
our results and those from the previous French study may seem
paradoxical, since some of the patients in the previous study had
severe symptoms (sciatica). The principal explanation for the
difference probably lies in the definition of persistent back pain
between the 2 studies: no pain in our study (a stricter definition, as
patients undoubtedly define it), and no decrease in pain in the
previous study. Finally, in the first French study, only 64% of
patients were totally free from LBP.
Limitations
Randomized controlled trials are widely accepted as the criterion
standard in assessing the effectiveness of specific therapies [42].
However, nonrandomized evaluation design is now widely
accepted as quasi-experimental design that can contribute
important data on the efficacy or effectiveness of interventions
[43,44], especially to evaluate public health interventions [31].
Moreover, quasi-experimental study designs that use control
groups and pretests are considered to be the soundest of
nonrandomized evaluations in terms of establishing causality
[45]. In our study, the individual randomization of patients was
not appropriate, since the GP was considered part of the
intervention, which mainly consisting of information and educa-
tion. GPs in the intervention arm were given the ‘‘back book’’ and
those in the control group were not. Furthermore, during the
course of our study, no LBP-centred intervention (press release or
Heath Care Services intervention) that could have affected the
evaluation of the impact of the ‘‘back book’’ was implemented in
Table 2. Demographic and professional characteristics, and personal history of back pain of GPs, GPs’ formation of and self-
reported attitude about acute low back pain, and GPs’ self-reported recommendations for chronic low back pain
..................................................................................................................................................
Whole sample of GPs N=709 Intervention practices N=340 Control practices N=369 p-value (t-test or Chi2)
Age mean (SD) 48.0 (7.0) 48.2 (6.6) 47.9 (7.4) p=0.71
Gender (M) 563 (79.5%) 269 (79.1%) 294 (79.9%) p=0.80
Years of practice
,10 93 (13.2%) 39 (11.6%) 54 (14.7%) p=0.16
10–20 296 (42.0%) 155 (46.0%) 141 (38.4%)
21–30 279 (39.6%) 129 (38.3%) 150 (40.9%)
.30 36 (5.2%) 14 (4.1%) 22 (6.0%)
Environment of practice
Rural 216 (30.5%) 116 (34.1%) 100 (27.1%) p=0.10
Urban 390 (69.1%) 222 (65.3%) 268 (72.6%)
Rural and urban 3 (0.4%) 2 (0.6%) 1 (0.3%)
Personal history of back pain
Acute 353 (49.9%) 171 (50.4%) 182 (49.3%) p=0.77
Recurrent 234 (33.0%) 108 (31.9%) 126 (34.2%) p=0.52
Chronic 102 (14.4%) 52 (15.3%) 50 (13.6%) p=0.49
Self-limitation of physical activity for back pain
Never 215 (49.9%) 96 (47.5%) 119 (52.0%) p=0.61
Rarely 185178 (42.9%) 90 (44.6%) 95 (41.5%)
Frequently 23 (5.3%) 13 (6.4%) 10 (4.4%)
Always 8 (1.9%) 3 (1.5%) 5 (2.1%)
GPs’ education about back pain
Education session on back pain in the
last 3 years (yes)
316 (46.4%) 154 (47.2%) 162 (45.6%) p=0.67
GPs’ attitude about back pain
Specific information delivered (yes) 586 (85.8%) 281 (85.9%) 305 (85.7%) p=0.92
Recommended sick leave duration for acute back pain
#3 days 59 (8.4%) 30 (9.0%) 29 (7.9%) p=0.54
3–8 days 570 (81.3%) 266 (79.6%) 304 (82.8%)
.8 days 72 (10.3%) 38 (11.4%) 34 (9.3%)
Physical activities recommended during sick leave for acute back pain
Bed rest 37 (5.4%) 17 (5.2%) 20 (5.5%) P=0.13
Rest 454 (65.7%) 204 (62.2%) 250 (68.9%)
Maximum bearable activity 200 (28.9%) 107 (32.6%) 93 (25.6%)
GPs’ FABQ Phys score (range 0–24) 9.6 (4.8) 9.2 (4.5) 10.0 (5.0) P=0.10
GPs’ FABQ Work score (range 0–42) 17.5 (6.7) 17.6 (6.7) 17.4 (6.6) P=0.69
Values are numbers (percentages) or m6SD
doi:10.1371/journal.pone.0000706.t002
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PLoS ONE | www.plosone.org 6 August 2007 | Issue 8 | e706any of the included geographic areas. Finally, we did not perform
a cluster randomized study by randomizing GPs practices to
intervention or control because we assumed that the risk of contact
between GPs in control and intervention practices during the trial
would have been higher than with a quasi-experimental design
with geographic stratification.
The main analysis was conducted on a per protocol population.
However, the proportion of patients lost to follow-up (15%) is
acceptable and was similar in both arms. Moreover, patients lost to
follow-up did not differ from those evaluated at 3 months in terms of
baseline characteristics. Finally, to provide data on an intention-to-
treat basis, we conducted a sensitivity analysis using two scenarios
(worst and best-case imputation), which were highly unrealistic.
Another possible limitation is that 2 procedures were used to
record data at follow-up: visits to GPs and phone interviews.
Phone interviews were used to decrease the number of patients lost
to follow-up and were conducted by a trained research assistant.
Outcome measures were easy to record by phone and the
proportion of patients for whom data were collected by phone did
not differ between the control and intervention groups. The
difference in proportion of patients with persistent pain between
phone and face-to-face interviews is probably a result of patient
improvement. The patients without persistent pain were less likely
to visit their doctors at 3 months than patients with persistent pain.
Only patients reporting persistent pain were reassessed at 3-
month follow-up, which limits the ability of this study to detect
Table 3. Follow-up assessment at 3 months
..................................................................................................................................................
Whole sample
N=2337
Intervention group
N=1135
Control group
N=1202
Percentage or mean
difference (95% CI)
P value* (Chi-
square or t-test)
P value** (adjusted
for cluster effect)
Persistent back pain 289 (12.4%) 119 (10.5%) 170 (14.1%) 23.6 (26.3; 21.0) 0.0072 0.0131
Visit to spine specialist 680 (29.4%) 305 (27.2%) 375 (31.5%) 24.3 (28.0 ; 20.5) 0.0253 0.0566
Spine imaging
Plain radiography 676 (29.2%) 327 (29.1%) 349 (29.2%) 20.1 (23.8 ; 3.6) 0.9428 0.8099
Computed tomography 194 (8.4%) 89 (7.9%) 105 (8.8%) 20.9 (23.1 ; 1.4) 0.4469 0.4379
Magnetic resonance imaging 45 (1.9%) 24 (2.1%) 21 (1.8%) 0.3 (20.7 ; 1.5) 0.5114 0.6886
Sick leave
Yes 1037 (44.9%) 503 (45.0%) 534 (44.8%) 0.2 (24.9 ; 4.3) 0.9250 0.9132
Sick leave duration (m6SD) 6.5614.4 6.0612.9 6.9615.7 20.9 (22.0 ; 0.4) 0.1592 0.2847
Analgesic intake 1964 (84.0%) 936 (82.5%) 1028 (85.5%) 23.0 (26.0 ; 20.1) 0.0437
NSAID intake 1008 (43.1%) 447 (39.4%) 561 (46.7%) 27.3 (211.3 ; 23.3) 0.0004 0.0103
Muscle-relaxant intake 864 (37.0%) 374 (32.9%) 490 (40.8%) 27.9 (211.7 ; 23.9) ,0.0001 0.0176
Information about Physical
activities
0.0003 0.0020
Very satisfied 1699 (73.7%) 868 (77.4%) 831 (70.3%) 7.1 (3.5 ; 10.7)
Rather satisfied 437 (19.0%) 194 (17.3%) 243 (20.5%) 23.6 (26.4 ; 20.1)
Rather unsatisfied 152 (6.6%) 55 (4.9%) 97 (8.2%) 23.2 (25.3 ; 21.3)
Unsatisfied 17 (0.7%) 5 (0.4%) 12 (1.0%) 20.6 (21.3 ; 0.1)
When to consult a physician 0.0010 0.0052
Very satisfied 1428 (62.0%) 739 (66.0%) 689 (58.2%) 7.8 (3.8 ; 11.8)
Rather satisfied 632 (27.5%) 281 (25.1%) 351 (29.7%) 24.6 (28.2 ; 21.0)
Rather unsatisfied 215 (9.3%) 86 (7.7%) 129 (10.9%) 23.2 (25.6 ; 20.8)
Unsatisfied 27 (1.2%) 13 (1.3%) 14 (1.2%) 0.1 (20.9 ; 0.9 )
How to prevent a new episode
of back pain
0.0033 0.0243
Very satisfied 1290 (56.0%) 660 (58.8%) 630 (53.3%) 5.5 (1.5 ; 9.6)
Rather satisfied 750 (32.6%) 359 (32.0%) 391 (33.1%) 21.1 (24.9 ; 2.7)
Rather unsatisfied 245 (10.6%) 97 (8.7%) 148 (12.5%) 23.8 (26.4 ; 21.4)
Unsatisfied 19 (0.8%) 6 (0.5%) 13 (1.1%) 20.6 (21.3 ; 0.2)
Medication intake 0.7090 0.9901
Very satisfied 1531 (66.4%) 743 (66.3%) 788 (66.6%) 20.3 (24.2 ; 3.5)
Rather satisfied 622 (27.0%) 309 (27.5%) 313 (26.5%) 1.0 (22.5 ; 4.7)
Rather unsatisfied 142 (6.2%) 66 (5.9%) 76 (6.4%) 20.5 (22.5 ; 1.4)
Unsatisfied 9 (0.4%) 3 (0.3%) 6 (0.5%) 20.2 (20.8 ; 0.3)
Values are numbers (%); NSAID=nonsteroidal anti-inflammatory drug
*P value when computing absolute difference
**P value when taking into account the cluster effect
doi:10.1371/journal.pone.0000706.t003
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PLoS ONE | www.plosone.org 7 August 2007 | Issue 8 | e706effects of the intervention on outcome measures that may influence
back-pain recurrence such as disability and fear-avoidance beliefs.
Finally, the sample size calculation did not take into account the
cluster effect, which resulted in a lower power of our study, but
which has no impact since the study results were positive.
Overall evidence
Low-tech and easy-to-disseminate interventions have enormous
promise in LBP interventions. The level of improvement described
in this study is modest, but the cost and complexity of the
intervention is minimal. Therefore, the implications and general-
izability of this intervention are substantial.
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